The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
about
Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studiesThe Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsPCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancerSignificance of the TMPRSS2:ERG gene fusion in prostate cancerGenetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse modelsEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies.Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Prognostic outlier genes for enhanced prostate cancer treatment.Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancerThe role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients.Emerging proteomics biomarkers and prostate cancer burden in Africa.Current early diagnostic biomarkers of prostate cancerSPINK1 protein expression and prostate cancer progression.Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.The role of epithelial plasticity in prostate cancer dissemination and treatment resistancePotential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.The Molecular Taxonomy of Primary Prostate Cancer.Genomic rearrangements in prostate cancer.TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patientsProstate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancerObesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerEvaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.Molecular differences in transition zone and peripheral zone prostate tumors.RNA biomarkers to facilitate the identification of aggressive prostate cancerInsulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG statusDietary lycopene intake and risk of prostate cancer defined by ERG protein expressionERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerERG rearrangement as a novel marker for predicting the extra-prostatic extension of clinically localised prostate cancer.Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer studyGenetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
P2860
Q24289356-8EFE2AC3-1E80-4000-A3B7-FB52DEADFD08Q26750672-5180DC4D-5986-442F-93C8-23C6B9EDC2F7Q26752933-15C4F5D9-1278-4751-B748-632EA5C3B54BQ27008556-2A6845E7-F4F0-4832-BFCC-9C2EC1287C8BQ27311359-DB16A096-2D19-4431-BF7E-44200F5ED308Q27323950-82E9D234-FDAA-49B3-BCBD-8470F8A0B706Q30238639-97B9ECC4-F846-4363-8365-E75D186CDF3EQ30240027-283110EE-CC36-472C-A68F-34FE65A83CF7Q30244674-C0B62AAF-D7CB-47E4-9552-E46DC47CAC5EQ33862890-25FA1EB5-4CAD-43BC-BDA9-D76B347A438CQ33876961-FACCA59F-6458-4D91-8746-E3340397B97BQ33914221-C796936F-FA8B-4744-8F70-187DE831E0CDQ33922390-613A85B2-08E1-4282-9AFE-9818466040FCQ34203149-202A6B6D-673C-450D-A618-4E142DC525B9Q34287725-C964AFEB-D49F-407E-A317-5D9D32E82A0BQ34505037-C0CF2D76-14AB-4477-84FF-E65E7D822D82Q34536729-5068C108-B90B-4D4B-B2B3-1A72FF035DDBQ34674332-1088F2C0-D47C-4587-B68D-BCDEB5C84DA9Q34722101-6D3F86C0-9568-4876-9618-1BBBCC533811Q35088099-A1460A35-0635-4513-A981-7CA56F34D760Q35091321-EA8D8F24-6C86-4865-9465-37E666499D1BQ35132292-4FBC2A38-AAAC-4B08-A29C-E9D503ECB89CQ35406347-4CFF7BDC-88C1-439B-80F6-E262A93DABCCQ35535396-4139B503-86DA-4C4C-9F70-46C4329B4A6AQ35582540-285A91A9-272E-4808-BB09-7D41594ABBA6Q35690915-7D3C02AE-391D-4FAE-80EF-8D6095F67F6EQ36035812-08EEDA51-A2D8-4B46-A663-C3B5EEC2AA74Q36067872-57423A4C-7BA5-42C2-B67F-511E6D4C5B43Q36067907-169A0DE4-6D22-4B58-AD93-CEB9F5D10A76Q36260364-A36F7148-3C82-4332-A99E-2CBA8B9B6C0FQ36381818-FF0AE486-5374-48E4-9D84-7522C4E1311AQ36606672-008A3E7B-024B-44FF-9569-C9B7B8D32E66Q36638207-FADBE868-5DAC-4C01-9FFC-AF7E4B545C31Q36741911-B4342A03-E322-43C4-9A01-E3B1EC7604C8Q36797979-B204E86C-507C-440F-BB9F-63C2CF41F0D2Q36848024-C125D532-06F4-4810-AB9D-49091A9FCC92Q36887707-42E50939-AABA-4964-BBFE-B75BD407AD57Q36918116-7D1FF069-A890-492C-8552-0D09CFA8CB10Q37100101-CAC69D22-A047-49AB-93DC-87CC8EB3AD5FQ37139054-D26736C4-0B3B-4D24-97E3-A51D91FC93C5
P2860
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The TMPRSS2:ERG rearrangement, ...... cohort study and meta-analysis
@en
type
label
The TMPRSS2:ERG rearrangement, ...... cohort study and meta-analysis
@en
prefLabel
The TMPRSS2:ERG rearrangement, ...... cohort study and meta-analysis
@en
P2093
P2860
P50
P1476
The TMPRSS2:ERG rearrangement, ...... cohort study and meta-analysis
@en
P2093
Andreas Pettersson
Azra H Ligon
Catherine Suppan
Christopher Sweeney
Edward C Stack
Howard D Sesso
Kathryn L Penney
Lauren Kunz
Martin G Sanda
Michael J Pitt
P2860
P304
P356
10.1158/1055-9965.EPI-12-0042
P50
P577
2012-06-26T00:00:00Z